SUPPLEMENTARY MATERIAL
Diabetes
DIABETES
The authors thank the staff in the Turku PET Centre, University of Turku, and the laboratory personnel in the Turku University Hospital Laboratory for their proficient assistance in conducting the study. This study was conducted within the Centre of Excellence in Cardiovascular and Metabolic Research, supported by the Academy of Finland, the University of Turku, Turku University Hospital, and Åbo Akademi University.Dr. Knuuti received consultancy fees from GE Healthcare and AstraZeneca and speaker fees from GE Healthcare, Bayer, Lundbeck, Boehringer-Ingelheim, and Merck, outside of the submitted work. The other authors report no conflicts of interest in this work. The results of the study are presented clearly, honestly, and without fabrication, falsification, or inappropriate data manipulation. The results of the present study do not constitute endorsement by the American College of Sports Medicine.Author contributions: I. H. A. H., K. K. K., J. K., T. V., and T. S. contributed to the conception and design of research; T. S., M. K., S. L., T. G., and N. H. performed the experiments; H. V.-Y., T. S., N. H., and E. L. analyzed the data; T. S. drafted the manuscript. All authors edited and revised the manuscript. All authors approved the final version of the manuscript.The study was financially supported by the Finnish Cultural Foundation, the Juho Vainio Foundation, Academy of Finland, the Hospital District of Southwest Finland, the Yrjö Jahnsson Foundation, the Turku University Foundation, Diabetestutkimussäätiö (the Finnish Diabetes Research Foundation), and TYKS-foundation.Data sharing: Data are available upon reasonable request from the corresponding author.Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s Web site (